General situation of Ningbo Tianheng Pharmaceutical Co., Ltd.

Tianheng was founded in July 1992 1. Engaged in medicine for 20 years, has passed the national GMP certification. The enterprise has domestic first-class medical science and technology strength and medical science and technology research center. In 2005, it first set up a postdoctoral research mobile station. Postdoctoral workstations have successfully developed a number of national second-class and fourth-class new drugs that are leading in China or even reaching the world advanced level, effectively filling the gap in the domestic pharmaceutical industry. Ningbo pharmaceutical enterprises are among the best in high-tech research and technology, high-tech products, economic benefits and development speed, and have won more than 50 awards. At the same time, as the first batch of national high-tech enterprises, it passed the evaluation again on 20 1 1. On the basis of the existing factory area of more than 60,000 square meters, the enterprise plans to build a new factory area and a new workshop to put into operation as soon as possible. Advanced production equipment and product technology have reached the domestic leading level. The main products of the enterprise are "Shu Dan", "Shu Xing" and "Shu Lida". So far, a variety of national second-class and fourth-class new drugs have been developed, and there are 96 products and more than 70 varieties of raw materials, injections, tablets and other models, of which more than 20 varieties have been rated as national key new products, included in the national torch plan, won the National Science and Technology Progress Award and the Zhejiang Science and Technology Progress Award, and won the National Small and Medium-sized Innovation and Technology Award. And has declared two well-known trademarks and two provincial famous trademarks. The marketing network is spread all over the country and the marketing team is growing day by day. Products sell well in China, and exported to the United States, Japan, India and other places, well received by domestic and foreign customers. Enterprise scale, production and sales profits and taxes rank among the top three in the region, and it is a large taxpayer in the region, and has been awarded the title of A-level taxpayer in Ningbo for many years. The new balance in the new century, the pursuit of Excellence, with the introduction of venture capital and the operation of listing, will achieve a gorgeous turn, climb the peak of world medical science and technology, serve human health and move towards higher goals.